Novo Nordisk Inc. has announced the FDA’s approval of insulin detemir injection of rDNA origin (Levemir®) for use in children. This basal (long-acting) form of insulin lasts for up to 24 hours and causes little weight change in adults.

It is indicated for once-daily or twice-daily subcutaneous administration for adults and children with type-1 diabetes mellitus or adults with type-2 diabetes mellitus who require long-acting insulin to control hyperglycemia.

This product was approved for use in adults in June 2005.

Qualitest Pharmaceuticals, Inc., has issued a voluntary nationwide recall of two Accusure insulin syringes:

• 1/2 cc, 31 G, Short Needle, Lot No. 6JCB1; expiration date, October
2011; NDC 0603-7001-21, distributed between January 2007 and June 2007
• 1 cc, 31 G, Short Needle, Lot No. 7CPT1; expiration date, March
2012; NDC 0603-7002-21, distributed between May 2007 and June 2008

Read the rest of this entry »